BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36246827)

  • 21. Homozygous DUOXA2 mutation (p.Tyr138
    Sugisawa C; Higuchi S; Takagi M; Hasegawa Y; Taniyama M; Abe K; Hasegawa T; Narumi S
    Endocr J; 2017 Aug; 64(8):807-812. PubMed ID: 28626131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel CYP4V2 genotypes associated with Bietti crystalline dystrophy and atypical anterior segment phenotypes in Spanish patients.
    García-García GP; Martínez-Rubio M; Moya-Moya MA; Pérez-Santonja JJ; Escribano J
    Acta Ophthalmol; 2018 Nov; 96(7):e865-e873. PubMed ID: 29691984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation of
    Han XY; Zhang LQ; Tang JY; Huang LZ; Tang R; Qu JF
    Int J Ophthalmol; 2022; 15(6):940-946. PubMed ID: 35814885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations.
    Lee KY; Koh AH; Aung T; Yong VH; Yeung K; Ang CL; Vithana EN
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3812-6. PubMed ID: 16186368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and genetic findings in a family with NMNAT1-associated Leber congenital amaurosis: case report and review of the literature.
    Hedergott A; Volk AE; Herkenrath P; Thiele H; Fricke J; Altmüller J; Nürnberg P; Kubisch C; Neugebauer A
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2239-46. PubMed ID: 26464178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exome sequencing identifies compound heterozygous mutations in CYP4V2 in a pedigree with retinitis pigmentosa.
    Wang Y; Guo L; Cai SP; Dai M; Yang Q; Yu W; Yan N; Zhou X; Fu J; Guo X; Han P; Wang J; Liu X
    PLoS One; 2012; 7(5):e33673. PubMed ID: 22693542
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Darki F; Fekri S; Farhangmehr S; Ahmadieh H; Dehghan MH; Elahi E
    J Curr Ophthalmol; 2019 Jun; 31(2):172-179. PubMed ID: 31317096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystals deposits in the anterior and posterior lens cortex in Bietti corneo-retinal dystrophy.
    Louati Y; Vaclavik V; Moulin A; Schorderet D; Munier FL; Viet Tran H
    Ophthalmic Genet; 2021 Dec; 42(6):773-779. PubMed ID: 34310258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant.
    Nakano M; Kelly EJ; Wiek C; Hanenberg H; Rettie AE
    Mol Pharmacol; 2012 Oct; 82(4):679-86. PubMed ID: 22772592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodal imaging features and genetic findings in Bietti crystalline dystrophy.
    Wang W; Chen W; Bai X; Chen L
    BMC Ophthalmol; 2020 Aug; 20(1):331. PubMed ID: 32799831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype and Long-term Clinical Course of Bietti Crystalline Dystrophy in Korean and Japanese Patients.
    Murakami Y; Koyanagi Y; Fukushima M; Yoshimura M; Fujiwara K; Akiyama M; Momozawa Y; Ueno S; Terasaki H; Oishi A; Miyata M; Ikeda H; Tsujikawa A; Mizobuchi K; Hayashi T; Fujinami K; Tsunoda K; Park JY; Han J; Kim M; Lee CS; Kim SJ; Park TK; Joo K; Woo SJ; Ikeda Y; Sonoda KH
    Ophthalmol Retina; 2021 Dec; 5(12):1269-1279. PubMed ID: 33636399
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Meng X; Li Q; Guo H; Xu H; Li S; Yin Z
    J Ophthalmol; 2017; 2017():4156386. PubMed ID: 28848678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of Lipid Droplets in a Novel Bietti Crystalline Dystrophy Zebrafish Model With Impaired PPARα Pathway.
    Gao P; Jia D; Li P; Huang Y; Hu H; Sun K; Lv Y; Chen X; Han Y; Zhang Z; Ren X; Wang Q; Liu F; Tang Z; Liu M
    Invest Ophthalmol Vis Sci; 2022 May; 63(5):32. PubMed ID: 35616930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current perspectives in Bietti crystalline dystrophy.
    García-García GP; Martínez-Rubio M; Moya-Moya MA; Pérez-Santonja JJ; Escribano J
    Clin Ophthalmol; 2019; 13():1379-1399. PubMed ID: 31440027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.
    Bai Y; Li J; Wang X
    J Ovarian Res; 2017 Mar; 10(1):16. PubMed ID: 28288674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotype phenotype analysis of Bietti's crystalline dystrophy in patients with CYP4V2 mutations.
    Lai TY; Ng TK; Tam PO; Yam GH; Ngai JW; Chan WM; Liu DT; Lam DS; Pang CP
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5212-20. PubMed ID: 17962476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular findings in three Japanese patients with crystalline retinopathy.
    Jin ZB; Ito S; Saito Y; Inoue Y; Yanagi Y; Nao-I N
    Jpn J Ophthalmol; 2006; 50(5):426-431. PubMed ID: 17013694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AAV2-mediated gene therapy for Bietti crystalline dystrophy provides functional CYP4V2 in multiple relevant cell models.
    Wang JH; Lidgerwood GE; Daniszewski M; Hu ML; Roberts GE; Wong RCB; Hung SSC; McClements ME; Hewitt AW; Pébay A; Hickey DG; Edwards TL
    Sci Rep; 2022 Jun; 12(1):9525. PubMed ID: 35680963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Photoreceptors in Bietti Crystalline Dystrophy with CYP4V2 Mutations Using Adaptive Optics Scanning Laser Ophthalmoscopy.
    Miyata M; Ooto S; Ogino K; Gotoh N; Morooka S; Makiyama Y; Hasegawa T; Sugahara M; Hata M; Yamashiro K; Yoshimura N
    Am J Ophthalmol; 2016 Jan; 161():196-205.e1. PubMed ID: 26521715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.